Live Chat ×
Skip to main content

Diagnostic Challenges in Prostate Pathology

Evaluated by: 
David B. Kaminsky, M.D., FIAC, October 20, 2017
Original release date: January 8, 2018
Access to this course expires on: October 20, 2020, at 11:59 PM Pacific Time
CME/SAMs 3.75

Course Description

Specimens obtained from prostate needle core biopsies, transurethral resection of prostate (TURP) and radical prostatectomy are frequently handled in both academic institutions and private practices by general surgical pathologists and/or urologic pathologists. These specimens still continue to pose diagnostic challenges in day to day practice. We will select cases that illustrate recurrent diagnostic problems and challenges in prostate pathology, and discuss how to approach them and make accurate diagnoses.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Become familiar with benign mimickers of prostate cancer
  • Recognize variants of prostate cancer and secondary tumors involving the prostate
  • Become familiar with issues and pitfalls regarding staging of prostate cancer
  • Recognize variants of prostate cancer and associated mimickers. 
  • Understand the clinical implications and appropriate management of HGPIN and atypical glands (ASAP) detected on prostate needle biopsy
  • Become familiar with the diagnostic pitfalls in diagnosing unusual variants of prostate cancer
  • Discuss the recently updated definition of prostate cancer grading patterns, its applicability and the new grading system

Continuing Medical Education and Maintenance of Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 3.75   AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3.75 SAM/Part II credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Adeboye O. Osunkoya, M.D., Cristina Magi-Galluzzi, M.D., Ph.D. 

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Not A Member? Click Here